Literature DB >> 33667812

Predicting presumed serious infection among hospitalized children on central venous lines with machine learning.

Azade Tabaie1, Evan W Orenstein2, Shamim Nemati3, Rajit K Basu2, Swaminathan Kandaswamy2, Gari D Clifford4, Rishikesan Kamaleswaran4.   

Abstract

BACKGROUND: Presumed serious infection (PSI) is defined as a blood culture drawn and new antibiotic course of at least 4 days among pediatric patients with Central Venous Lines (CVLs). Early PSI prediction and use of medical interventions can prevent adverse outcomes and improve the quality of care.
METHODS: Clinical features including demographics, laboratory results, vital signs, characteristics of the CVLs and medications used were extracted retrospectively from electronic medical records. Data were aggregated across all hospitals within a single pediatric health system and used to train machine learning models (XGBoost and ElasticNet) to predict the occurrence of PSI 8 h prior to clinical suspicion. Prediction for PSI was benchmarked against PRISM-III.
RESULTS: Our model achieved an area under the receiver operating characteristic curve of 0.84 (95% CI = [0.82, 0.85]), sensitivity of 0.73 [0.69, 0.74], and positive predictive value (PPV) of 0.36 [0.34, 0.36]. The PRISM-III conversely achieved a lower sensitivity of 0.19 [0.16, 0.22] and PPV of 0.30 [0.26, 0.34] at a cut-off of ≥ 10. The features with the most impact on the PSI prediction were maximum diastolic blood pressure prior to PSI prediction (mean SHAP = 3.4), height (mean SHAP = 3.2), and maximum temperature prior to PSI prediction (mean SHAP = 2.6).
CONCLUSION: A machine learning model using common features in the electronic medical records can predict the onset of serious infections in children with central venous lines at least 8 h prior to when a clinical team drew a blood culture.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CLABSI; Infection; Machine learning; Predictive model; Sepsis

Mesh:

Year:  2021        PMID: 33667812      PMCID: PMC9207586          DOI: 10.1016/j.compbiomed.2021.104289

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   6.698


  31 in total

1.  From Local Explanations to Global Understanding with Explainable AI for Trees.

Authors:  Scott M Lundberg; Gabriel Erion; Hugh Chen; Alex DeGrave; Jordan M Prutkin; Bala Nair; Ronit Katz; Jonathan Himmelfarb; Nisha Bansal; Su-In Lee
Journal:  Nat Mach Intell       Date:  2020-01-17

2.  Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts.

Authors:  Marlene R Miller; Michael Griswold; J Mitchell Harris; Gayane Yenokyan; W Charles Huskins; Michele Moss; Tom B Rice; Debra Ridling; Deborah Campbell; Peter Margolis; Stephen Muething; Richard J Brilli
Journal:  Pediatrics       Date:  2010-01-11       Impact factor: 7.124

Review 3.  A machine learning approach for mortality prediction only using non-invasive parameters.

Authors:  Guang Zhang; JiaMeng Xu; Ming Yu; Jing Yuan; Feng Chen
Journal:  Med Biol Eng Comput       Date:  2020-07-20       Impact factor: 2.602

4.  Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

Authors:  Chanu Rhee; Raymund Dantes; Lauren Epstein; David J Murphy; Christopher W Seymour; Theodore J Iwashyna; Sameer S Kadri; Derek C Angus; Robert L Danner; Anthony E Fiore; John A Jernigan; Greg S Martin; Edward Septimus; David K Warren; Anita Karcz; Christina Chan; John T Menchaca; Rui Wang; Susan Gruber; Michael Klompas
Journal:  JAMA       Date:  2017-10-03       Impact factor: 56.272

Review 5.  Using objective clinical data to track progress on preventing and treating sepsis: CDC's new 'Adult Sepsis Event' surveillance strategy.

Authors:  Chanu Rhee; Raymund Barretto Dantes; Lauren Epstein; Michael Klompas
Journal:  BMJ Qual Saf       Date:  2018-09-25       Impact factor: 7.035

6.  Objective Sepsis Surveillance Using Electronic Clinical Data.

Authors:  Chanu Rhee; Sameer Kadri; Susan S Huang; Michael V Murphy; Lingling Li; Richard Platt; Michael Klompas
Journal:  Infect Control Hosp Epidemiol       Date:  2015-11-03       Impact factor: 3.254

7.  Sociomarkers and biomarkers: predictive modeling in identifying pediatric asthma patients at risk of hospital revisits.

Authors:  Eun Kyong Shin; Ruhi Mahajan; Oguz Akbilgic; Arash Shaban-Nejad
Journal:  NPJ Digit Med       Date:  2018-10-02

8.  Pediatric Severe Sepsis Prediction Using Machine Learning.

Authors:  Sidney Le; Jana Hoffman; Christopher Barton; Julie C Fitzgerald; Angier Allen; Emily Pellegrini; Jacob Calvert; Ritankar Das
Journal:  Front Pediatr       Date:  2019-10-11       Impact factor: 3.418

9.  Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker.

Authors:  Kentaro Iwasawa; Wataru Suda; Tomoyuki Tsunoda; Manari Oikawa-Kawamoto; Shuichiro Umetsu; Lena Takayasu; Ayano Inui; Tomoo Fujisawa; Hidetoshi Morita; Tsuyoshi Sogo; Masahira Hattori
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

10.  Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients.

Authors:  Akram Mohammed; Yan Cui; Valeria R Mas; Rishikesan Kamaleswaran
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

View more
  3 in total

1.  Prediction of Lumbar Drainage-Related Meningitis Based on Supervised Machine Learning Algorithms.

Authors:  Peng Wang; Shuwen Cheng; Yaxin Li; Li Liu; Jia Liu; Qiang Zhao; Shuang Luo
Journal:  Front Public Health       Date:  2022-06-28

2.  Predicting bloodstream infection outcome using machine learning.

Authors:  Yazeed Zoabi; Orli Kehat; Dan Lahav; Ahuva Weiss-Meilik; Amos Adler; Noam Shomron
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

3.  DeepMC-iNABP: Deep learning for multiclass identification and classification of nucleic acid-binding proteins.

Authors:  Feifei Cui; Shuang Li; Zilong Zhang; Miaomiao Sui; Chen Cao; Abd El-Latif Hesham; Quan Zou
Journal:  Comput Struct Biotechnol J       Date:  2022-04-26       Impact factor: 6.155

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.